A Multi-component Intervention to Improve Medication Adherence in People With Depressive Disorders

NCT ID: NCT03668457

Last Updated: 2023-04-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

170 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-01

Study Completion Date

2022-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: The study of medication adherence in depression (MAPDep study) aims to evaluate the effectiveness and cost-effectiveness of a multi-component strategy to enhance patient-centered care to improve adherence toward medications in patients with depression, formed by an educational intervention to psychiatrists and/or a collaborative care intervention group to patients and relatives plus a reminder system through the use of a mobile APP.

Methods: The objective will be assessed under an open multicenter, clinical controlled trial with random allocation by clusters to one of three interventions or to usual care (control arm). In group 1 only patients and family members receive intervention, in group 2 only psychiatrists receive intervention, and group 3 is a combined intervention for patients and psychiatrists. The main measure will be the change in medication adherence rate. Secondary endpoints are depression, emotional distress, health-related quality of life, physical functioning, patients' knowledge about their medications, provider beliefs regarding patient-centeredness, and healthcare resource utilization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depressive Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention to Patients

Only patients receive intervention

Group Type EXPERIMENTAL

Intervention to Patients

Intervention Type BEHAVIORAL

Multifaceted intervention consisting of:

1. A collaborative care management intervention, including depression education, medication management and behavioral activation.
2. Use of a medication reminder mobile app.

Control

Intervention Type OTHER

Other: Usual care Usual care for depressive disorder received in mental health units

Intervention to Psychiatrists

Psychiatrists receive the intervention. Their associated patients do not receive direct intervention although indirect intervention through professionals

Group Type EXPERIMENTAL

Intervention to Psychiatrists

Intervention Type BEHAVIORAL

Educational intervention consisting of theoretical and practical sessions to to improve communication and negotiation abilities, and to develop skills to promote patient-centered care and shared decision-making.

Control

Intervention Type OTHER

Other: Usual care Usual care for depressive disorder received in mental health units

Mixed Intervention

Patients and Psychiatrists associated with these patients receive intervention

Group Type EXPERIMENTAL

Intervention to Patients

Intervention Type BEHAVIORAL

Multifaceted intervention consisting of:

1. A collaborative care management intervention, including depression education, medication management and behavioral activation.
2. Use of a medication reminder mobile app.

Intervention to Psychiatrists

Intervention Type BEHAVIORAL

Educational intervention consisting of theoretical and practical sessions to to improve communication and negotiation abilities, and to develop skills to promote patient-centered care and shared decision-making.

Control

Intervention Type OTHER

Other: Usual care Usual care for depressive disorder received in mental health units

Control

Psychiatrists provide the usual care Patients receive usual care

Group Type OTHER

Control

Intervention Type OTHER

Other: Usual care Usual care for depressive disorder received in mental health units

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention to Patients

Multifaceted intervention consisting of:

1. A collaborative care management intervention, including depression education, medication management and behavioral activation.
2. Use of a medication reminder mobile app.

Intervention Type BEHAVIORAL

Intervention to Psychiatrists

Educational intervention consisting of theoretical and practical sessions to to improve communication and negotiation abilities, and to develop skills to promote patient-centered care and shared decision-making.

Intervention Type BEHAVIORAL

Control

Other: Usual care Usual care for depressive disorder received in mental health units

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients:

* Patients with diagnosis of depressive disorder (major depressive disorder MDD and/or dysthymia) under pharmacological treatment
* Regular users of mobile phones
* Patients who have consulted their psychiatrist about their depression at least once in the previous 6 months
* Health professionals:

Psychiatrists have no intention of moving from their practice during the study period.

Exclusion Criteria

• Patient:

* Patients with history of current bipolar disorder and/or any psychotic disorder
* Insufficient language skills
* Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of La Laguna

OTHER

Sponsor Role collaborator

Servicio Canario de Salud

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

María del Mar Trujillo Martín, PhD

Role: PRINCIPAL_INVESTIGATOR

Servicio de Evaluación del Servicio Canario de la Salud

Carlos de las Cuevas Castresana, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of La Laguna

Tasmania del Pino-Sedeño, PhD

Role: PRINCIPAL_INVESTIGATOR

University of La Laguna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Servicio de Evaluación. Servicio Canario de Salud

Santa Cruz de Tenerife, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Del Pino-Sedeno T, Penate W, de Las Cuevas C, Valcarcel-Nazco C, Fumero A, Serrano-Perez PG, Acosta Artiles FJ, Ramos Garcia V, Leon Salas B, Bejarano-Quisoboni D, Trujillo-Martin MM. Effectiveness and cost-effectiveness of a multicomponent intervention to improve medication adherence in people with depressive disorders - MAPDep: a study protocol for a cluster randomized controlled trial. Patient Prefer Adherence. 2019 Feb 22;13:309-319. doi: 10.2147/PPA.S172963. eCollection 2019.

Reference Type DERIVED
PMID: 30863020 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI18-00767

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.